-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
GeneDx Holdings Corp. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q2 2024.
- GeneDx Holdings Corp. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$18.8M, a 499% decline year-over-year.
- GeneDx Holdings Corp. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$25.5M, a 176% decline year-over-year.
- GeneDx Holdings Corp. annual Nonoperating Income (Expense) for 2023 was $3.9M, a 94.4% decline from 2022.
- GeneDx Holdings Corp. annual Nonoperating Income (Expense) for 2022 was $69.6M, a 65.3% decline from 2021.
- GeneDx Holdings Corp. annual Nonoperating Income (Expense) for 2021 was $201M, a 30597% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)